Latest peptide research & news
Automatically aggregated from PubMed and biotech/pharma news feeds (FiercePharma, ScienceDaily), filtered to peptide-relevant stories. These link out to the original publishers — they are not authored by this site and are not an endorsement.
PubMed · peer-reviewed
Pancreatic δ cells are resistant to auto- and paracrine inhibition in human type-2 diabetes
Omar-Hmeadi M et al. · Proceedings of the National Academy of Sciences of the United States of America · 2026 Nov 3
Read at sourceSemaglutide and Panic Attacks: Active-Comparator Disproportionality Analysis, Temporal Assessment of Notoriety Bias and Evidence Triangulation in Post-Marketing Pharmacovigilance
Melamed B et al. · Pharmacoepidemiology and drug safety · 2026 Nov
Read at sourceGLP-1-Based Therapy in Type 1 Diabetes: Balancing Efficacy, Safety, and Patient Selection
Rossatto T et al. · Diabetes, obesity & metabolism · 2026 Oct 27
Read at sourceInterpreting Diabetic Retinal Outcomes After GLP-1 Receptor Agonist and Tirzepatide Initiation: Clinical Evidence and Its Limits
Wu B et al. · Diabetes, obesity & metabolism · 2026 Oct 27
Read at sourceSemaglutide for MASH in Japanese patients: findings consistent with the overall ESSENCE population
Nakagawa H · Journal of gastroenterology · 2026 Oct 27
Read at sourceA Multifunctional Biomimetic Hydrogel with Antibacterial and Antifibrotic Properties for Scar Minimizing Repair of Infected Skin Wounds
Liang S et al. · Acta biomaterialia · 2026 Oct 27
Read at sourceThe GLP-1 receptor agonist semaglutide reduces alcohol consumption and anxiety-like behaviors during withdrawal in Marchigian Sardinian alcohol-preferring rats
Palmisano M et al. · Neuropharmacology · 2026 Oct 27
Read at sourceEmerging Therapeutic Strategies for Child and Adolescent Obesity: A Narrative Review
Oliaro T et al. · Nutrients · 2026 Oct 21
Read at sourceChronic Intermittent Hypoxia and MASLD in Obstructive Sleep Apnea: A Critical Appraisal of Mechanistic and Causal Evidence
Cebuc Simeanu GM et al. · International journal of molecular sciences · 2026 Oct 21
Read at sourceEffectiveness of the Dual GLP-1R/GCGR Agonist Mazdutide in GSD IXc: A Case Report
Chen Y et al. · Journal of clinical medicine · 2026 Oct 20
Read at sourceGLP-1 Receptor Agonist Therapy in Patients with Cancer: A Review of Clinical Outcomes
Andronescu AC et al. · International journal of molecular sciences · 2026 Oct 18
Read at sourceCirculating α-Klotho Is Elevated in Breast Cancer and Positively Correlates with IGF-1
Ben Neriah S et al. · International journal of molecular sciences · 2026 Oct 18
Read at sourceBiliary and Pancreatic Safety of Incretin-Based Therapies in Obesity and Type 2 Diabetes: A Propensity-Matched Real-World Comparison of Tirzepatide, Semaglutide, and DPP-4 Inhibitors
Ghusn W et al. · Journal of clinical medicine · 2026 Oct 16
Read at sourceUrinary Stone Recurrence After Initiation of GLP-1-Based Therapy: A Romanian Retrospective Cohort Study of Clinical, Renal, and Hydration-Related Factors
Danau RA et al. · Journal of clinical medicine · 2026 Oct 16
Read at sourceCord Blood 3-Epi-25-Hydroxyvitamin D(3) and Autism-Related Cognitive Traits at Age 10 Years: An Exploratory Secondary Analysis of the KLOTHO Birth Cohort
Karras SN et al. · Nutrients · 2026 Oct 14
Read at sourceProgress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective
Ahmad I et al. · Pharmaceutics · 2026 Oct 9
Read at sourceRetatrutide as a Unimolecular GIP/GLP-1/Glucagon Receptor Tri-Agonist: Molecular Design, Pharmaceutical Development and Critical Interpretation of Emerging Phase 3 Evidence
Mateescu DM et al. · Pharmaceutics · 2026 Oct 9
Read at sourcePeptides in Aesthetic Dermatology: Classification, Fibroblast-Centered Mechanisms, Delivery Technologies, and Clinical Evidence
Yi KH et al. · Life (Basel, Switzerland) · 2026 Oct 2
Read at sourcePossibilities for Cytoprotective Liver Therapy, Stable Gastric Pentadecapeptide BPC 157, and Standard Agents-A Narrative Review
Sever M et al. · Pharmaceuticals (Basel, Switzerland) · 2026 Oct 1
Read at sourceCardiorenal Syndrome: Pathophysiology, Management, and the Challenge of Therapeutic Inertia
Gembillo G et al. · Medicina (Kaunas, Lithuania) · 2026 Sep 25
Read at sourceAssociation of Vitamin D Supplementation with VDR and CAMP Expression and Ulcer Healing in Diabetic Foot Infection Involving Biofilm-Forming Bacteria: An Exploratory Prospective Cohort Study
Benson R et al. · Pharmaceuticals (Basel, Switzerland) · 2026 Sep 23
Read at sourceBeyond Weight Loss and Glycemic Control: Molecular Mechanisms and Hypothesis-Generating Therapeutic Potential of Incretin-Based Therapies Against Peritoneal Fibrosis in Peritoneal Dialysis
Li YC et al. · Pharmaceuticals (Basel, Switzerland) · 2026 Sep 22
Read at sourceComparison of cardiac adverse event signal profiles for GLP-1 receptor agonists: an analysis of the FAERS database
Yildirim BO et al. · BMC cardiovascular disorders · 2026 Jul 31
Read at sourceFrom pathophysiology to therapy: dual and triple agonists as a new frontier in metabolic dysfunction-associated steatotic liver disease
Argano C et al. · Frontiers in pharmacology · 2026
Read at sourceMetabolic characteristics and diagnostic biomarkers of malnutrition in maintenance hemodialysis patients based on WGCNA analysis
Shi B et al. · Frontiers in physiology · 2026
Read at source